(WITHDRAWN)Prot#E5501-G000-202: A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of One-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects wit

Project: Research project

Project Details

StatusFinished
Effective start/end date1/15/1010/21/11

Funding

  • CTI Clinical Trial and Consulting Services (E5501-G000-202)
  • Eisai Medical Research Inc. (E5501-G000-202)